Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18620949rdf:typepubmed:Citationlld:pubmed
pubmed-article:18620949lifeskim:mentionsumls-concept:C1516985lld:lifeskim
pubmed-article:18620949lifeskim:mentionsumls-concept:C0278882lld:lifeskim
pubmed-article:18620949lifeskim:mentionsumls-concept:C0302523lld:lifeskim
pubmed-article:18620949lifeskim:mentionsumls-concept:C0700325lld:lifeskim
pubmed-article:18620949lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:18620949lifeskim:mentionsumls-concept:C0796545lld:lifeskim
pubmed-article:18620949lifeskim:mentionsumls-concept:C0677850lld:lifeskim
pubmed-article:18620949lifeskim:mentionsumls-concept:C0282461lld:lifeskim
pubmed-article:18620949lifeskim:mentionsumls-concept:C1521996lld:lifeskim
pubmed-article:18620949lifeskim:mentionsumls-concept:C0205088lld:lifeskim
pubmed-article:18620949pubmed:issue9633lld:pubmed
pubmed-article:18620949pubmed:dateCreated2008-7-14lld:pubmed
pubmed-article:18620949pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18620949pubmed:abstractTextAny benefit of adjuvant interferon alfa-2b for melanoma could depend on dose and duration of treatment. Our aim was to determine whether pegylated interferon alfa-2b can facilitate prolonged exposure while maintaining tolerability.lld:pubmed
pubmed-article:18620949pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18620949pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18620949pubmed:languageenglld:pubmed
pubmed-article:18620949pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18620949pubmed:citationSubsetAIMlld:pubmed
pubmed-article:18620949pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18620949pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18620949pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18620949pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18620949pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18620949pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18620949pubmed:statusMEDLINElld:pubmed
pubmed-article:18620949pubmed:monthJullld:pubmed
pubmed-article:18620949pubmed:issn1474-547Xlld:pubmed
pubmed-article:18620949pubmed:authorpubmed-author:EORTC...lld:pubmed
pubmed-article:18620949pubmed:authorpubmed-author:EggermontAlex...lld:pubmed
pubmed-article:18620949pubmed:authorpubmed-author:DummerReinhar...lld:pubmed
pubmed-article:18620949pubmed:authorpubmed-author:KeilholzUlric...lld:pubmed
pubmed-article:18620949pubmed:authorpubmed-author:SpatzAlainAlld:pubmed
pubmed-article:18620949pubmed:authorpubmed-author:SantinamiMari...lld:pubmed
pubmed-article:18620949pubmed:authorpubmed-author:GoreMartinMlld:pubmed
pubmed-article:18620949pubmed:authorpubmed-author:PuntCornelis...lld:pubmed
pubmed-article:18620949pubmed:authorpubmed-author:SuciuStefanSlld:pubmed
pubmed-article:18620949pubmed:authorpubmed-author:HauschildAxel...lld:pubmed
pubmed-article:18620949pubmed:authorpubmed-author:TestoriAlessa...lld:pubmed
pubmed-article:18620949pubmed:authorpubmed-author:MackieRonaRlld:pubmed
pubmed-article:18620949pubmed:authorpubmed-author:KruitWim H...lld:pubmed
pubmed-article:18620949pubmed:authorpubmed-author:KusicZvonkoZlld:pubmed
pubmed-article:18620949pubmed:authorpubmed-author:MusatElenaElld:pubmed
pubmed-article:18620949pubmed:authorpubmed-author:MarsdenJeremy...lld:pubmed
pubmed-article:18620949pubmed:authorpubmed-author:SalèsFrançois...lld:pubmed
pubmed-article:18620949pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18620949pubmed:day12lld:pubmed
pubmed-article:18620949pubmed:volume372lld:pubmed
pubmed-article:18620949pubmed:ownerNLMlld:pubmed
pubmed-article:18620949pubmed:authorsCompleteYlld:pubmed
pubmed-article:18620949pubmed:pagination117-26lld:pubmed
pubmed-article:18620949pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:18620949pubmed:meshHeadingpubmed-meshheading:18620949...lld:pubmed
pubmed-article:18620949pubmed:meshHeadingpubmed-meshheading:18620949...lld:pubmed
pubmed-article:18620949pubmed:meshHeadingpubmed-meshheading:18620949...lld:pubmed
pubmed-article:18620949pubmed:meshHeadingpubmed-meshheading:18620949...lld:pubmed
pubmed-article:18620949pubmed:meshHeadingpubmed-meshheading:18620949...lld:pubmed
pubmed-article:18620949pubmed:meshHeadingpubmed-meshheading:18620949...lld:pubmed
pubmed-article:18620949pubmed:meshHeadingpubmed-meshheading:18620949...lld:pubmed
pubmed-article:18620949pubmed:meshHeadingpubmed-meshheading:18620949...lld:pubmed
pubmed-article:18620949pubmed:meshHeadingpubmed-meshheading:18620949...lld:pubmed
pubmed-article:18620949pubmed:meshHeadingpubmed-meshheading:18620949...lld:pubmed
pubmed-article:18620949pubmed:meshHeadingpubmed-meshheading:18620949...lld:pubmed
pubmed-article:18620949pubmed:meshHeadingpubmed-meshheading:18620949...lld:pubmed
pubmed-article:18620949pubmed:meshHeadingpubmed-meshheading:18620949...lld:pubmed
pubmed-article:18620949pubmed:meshHeadingpubmed-meshheading:18620949...lld:pubmed
pubmed-article:18620949pubmed:meshHeadingpubmed-meshheading:18620949...lld:pubmed
pubmed-article:18620949pubmed:meshHeadingpubmed-meshheading:18620949...lld:pubmed
pubmed-article:18620949pubmed:meshHeadingpubmed-meshheading:18620949...lld:pubmed
pubmed-article:18620949pubmed:year2008lld:pubmed
pubmed-article:18620949pubmed:articleTitleAdjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial.lld:pubmed
pubmed-article:18620949pubmed:affiliationErasmus University Medical Center, Rotterdam, Netherlands. a.m.m.eggermont@erasmusmc.nllld:pubmed
pubmed-article:18620949pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18620949pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:18620949pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:18620949pubmed:publicationTypeMulticenter Studylld:pubmed
pubmed-article:18620949pubmed:publicationTypeClinical Trial, Phase IIIlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18620949lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18620949lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18620949lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18620949lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18620949lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18620949lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18620949lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18620949lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18620949lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18620949lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18620949lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18620949lld:pubmed